Announcement
14 Apr 2022
In April 2022, the Dutch Government announced financial support of EUR 78.8 million under the National Growth Fund for the "PharmaNL" project to support the Dutch pharmaceutical sector and the development of pharmaceutical products.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
14 Apr 2022
Revocation date:
No revocation date
Announced: 14 Apr 2022
In-kind grant
In force
On 14 April 2022, the "PharmaNL" project received financial support worth EUR 78.8 million (USD 85.6 million) from the Dutch government under the National Growth Fund. The project offers access to inn...
Sign in to see more
Related State Acts
Announced: 14 Apr 2022
Netherlands: Financial support for "Luchtvaart in Transitie" project to support development of aircraft technologies
Announced: 14 Apr 2022
Netherlands: Financial support for “Biotech Booster” project to support biotech sector
Announced: 14 Apr 2022
Netherlands: Further financial support to the “GroenvermogenNL” project for developing green hydrogen
Announced: 14 Apr 2022
Netherlands: Financial grant for “Zero emissie binnenvaart” project to support zero emission inland shipping
Announced: 14 Apr 2022
Netherlands: Financial support for “NXTGEN HIGHTECH” project to support development of high-tech equipment
Announced: 07 Sep 2020
Netherlands: EUR 20 billion National Growth Fund launched to support research and development
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70831
interventions
194
jurisdictions